Does borderline kidney allograft rejection always require treatment?

Transplantation

Volumn 90, Issue 4, 2010, Pages 427-432

  Németh, Dorottya ^a   Ovens, Jörg ^a   Opelz, Gerhard ^a   Sommerer, Claudia ^a   Döhler, Bernd ^a   Becker, Luis E ^a   Gross, Marie Luise ^a   Waldherr, Rüdiger ^a   Mieth, Markus ^a   Sadeghi, Mahmoud ^a   Schmidt, Jan ^a   Langer, Robert M ^b   Zeier, Martin ^a   Süsal, Caner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Borderline rejection; Foxp3; Kidney transplantation

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BLOOD SAMPLING; BORDERLINE KIDNEY ALLOGRAFT REJECTION; CELL ACTIVITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADULT; DNA PRIMERS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OPERON; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 77955966060     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e81b16     Document Type: Article

References (16)

1. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
2. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311.
3. Wang S, Jiang J, Guan Q, et al. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model. Transpl Immunol 2008; 19: 93.
4. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342.
5. Mansour H, Homs S, Desvaux D, et al. Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol 2008; 19:2277.
6. + regulatory T cells. Nat Immunol 2003; 4:330.
7. Alvarez CM, Opelz G, Garcia LF, et al. Expression of regulatory T-cell-related molecule genes and clinical outcome in kidney transplant recipients. Transplantation 2009; 87: 857.
8. Madden RL, Mulhern JG, Benedetto BJ, et al. Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients. Transpl Int 2000; 13:344.
9. Opelz G, Dohler B. Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation 2008; 85: 661.
10. Süsal C, Dohler B, Sadeghi M, et al. HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: A collaborative transplant study report. Transplantation 2009; 87: 1367.
11. Sakamoto R, Asonuma K, Zeledon Ramirez ME, et al. Forkhead Box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant. Exp Clin Transplant 2009; 7: 8.
12. + T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 2007; 20: 845.
13. Gonzalez A, Andre-Schmutz I, Carnaud C, et al. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nat Immunol 2001; 2: 1117.
14. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
15. Meehan SM, Siegel CT, Aronson AJ, et al. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 1999; 10: 1806.
16. + regulatory T cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19:2020.